Screening in partnership with Helix, Inc. could offer Princess Margaret Cancer Centre patients insights into hereditary health risks

Dr. Raymond Kim, Dr. Ari Morgenthau and genetic counsellors Larissa Peck and Laura Redondo at the Princess Margaret Cancer Centre in Toronto. The centre is the first Canadian hospital to join a cross-border genomic testing study.

Over the next five years, every patient treated at Canada’s largest cancer centre will have the opportunity to undergo genomic testing to see if major hereditary health risks lurk in their DNA.

The Princess Margaret Cancer Centre in Toronto announced Thursday that it would become the first Canadian hospital to join a cross-border collaboration involving 15 hospitals in the United States and Helix, Inc., a private American genomics company, that together plan to sequence the exomes of 1.6 million patients.

From The Globe and Mail via this RSS feed